IGC Pharma ( (IGC)) has issued an update. On January 5, 2026, IGC Pharma, Inc. entered into a subscription agreement with a group of investors for a registered direct offering of 779,997 shares of ...
POTOMAC, MARYLAND / ACCESS Newswire / January 5, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) to ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results